CTMX logo

CytomX Therapeutics (CTMX) Cash From Investing

Annual CFI

-$150.67 M
-$248.93 M-253.34%

December 31, 2023

Summary

Performance

1-Year Change

-253.34%

3-Year Change

-704.97%

5-Year Change

-2642.59%

15-Year Change

-24.25%

CTMX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.45%
CTMX annual cash flow from investing activities is higher than 11.45% of companies in Healthcare sector

High & Low

All-time High

$98.26 M
CTMX annual cash flow from investing activities is currently -253.34% below its historical high of $98.26 million

3-Year Low

-$150.67 M
CTMX annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CTMX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 11, 2025
CTMX next annual earnings announcement is scheduled for Mar 11, 2025

OtherCTMXcash flowmetrics:

Annual CFF

$30.23 M
CTMX annual cash flow from financing activities is $30.23 million

Annual CFO

-$56.03 M
CTMX annual cash flow from operations is -$56.03 million

Annual FCF

-$56.88 M
CTMX annual free cash flow is -$56.88 million

Annual CAPEX

$840.00 K
CTMX annual capital expenditures is $840.00 thousand

Quarterly CFI

$18.17 M
-$3.34 M-15.54%

September 30, 2024

Summary

Performance

3-Month Change

-15.54%

1-Year Change

+142.31%

3-Year Change

+142.31%

5-Year Change

+142.31%

CTMX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.71%
CTMX quarterly cash flow from investing activities is higher than 87.71% of companies in Healthcare sector

High & Low

All-time High

$99.82 M
CTMX quarterly cash flow from investing activities is currently -81.80% below its historical high of $99.82 million

3-Year Low

-$146.64 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTMX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 11, 2025
CTMX next earnings announcement is scheduled for Mar 11, 2025

OtherCTMXcash flowmetrics:

Quarterly CFF

$0.00
CTMX quarterly cash flow from financing activities is $0.00

Quarterly CFO

-$20.73 M
CTMX quarterly cash flow from operations is -$20.73 million

Quarterly FCF

-$20.75 M
CTMX quarterly free cash flow is -$20.75 million

Quarterly CAPEX

$19.00 K
CTMX quarterly capital expenditures is $19.00 thousand

TTM CFI

$97.43 M
+$61.11 M+168.22%

September 30, 2024

Summary

Performance

3-Month Change

+168.22%

1-Year Change

+252.9%

3-Year Change

+252.9%

5-Year Change

+252.9%

CTMX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.12%
CTMX TTM cash flow from investing activities is higher than 95.12% of companies in Healthcare sector

High & Low

All-time High

$143.26 M
CTMX TTM cash flow from investing activities is currently -31.99% below its historical high of $143.26 million

3-Year Low

-$150.67 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTMX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 11, 2025
CTMX next earnings announcement is scheduled for Mar 11, 2025

OtherCTMXcash flowmetrics:

TTM CFF

$5.52 M
CTMX TTM cash flow from financing activities is $5.52 million

TTM CFO

-$88.29 M
CTMX TTM cash flow from operations is -$88.29 million

TTM FCF

-$88.78 M
CTMX TTM free cash flow is -$88.78 million

TTM CAPEX

$496.00 K
CTMX TTM capital expenditures is $496.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CTMX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-253.3%+142.3%+252.9%
3 y3 years-705.0%+142.3%+252.9%
5 y5 years-2642.6%+142.3%+252.9%

CTMX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-253.3%at low-81.8%+112.4%-0.8%+164.7%
5 y5-year-253.3%at low-81.8%+112.4%-32.0%+164.7%
alltimeall time-253.3%at low-81.8%+112.1%-32.0%+161.0%

CytomX Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$18.17 M(-15.5%)
$97.43 M(+168.2%)
Jun 2024
-
$21.51 M(-52.1%)
$36.33 M(-11.1%)
Mar 2024
-
$44.88 M(+248.9%)
$40.85 M(-127.1%)
Dec 2023
-$150.67 M(-253.3%)
$12.87 M(-130.0%)
-$150.67 M(+136.5%)
Sep 2023
-
-$42.94 M(-264.9%)
-$63.72 M(+200.7%)
Jun 2023
-
$26.04 M(-117.8%)
-$21.19 M(-55.5%)
Mar 2023
-
-$146.64 M(-246.9%)
-$47.65 M(-148.5%)
Dec 2022
$98.26 M(+336.9%)
$99.82 M(<-9900.0%)
$98.26 M(-5549.8%)
Sep 2022
-
-$410.00 K(-0.5%)
-$1.80 M(-121.6%)
Jun 2022
-
-$412.00 K(-44.0%)
$8.34 M(-122.4%)
Mar 2022
-
-$736.00 K(+200.4%)
-$37.26 M(-265.7%)
Dec 2021
$22.49 M(-220.1%)
-$245.00 K(-102.5%)
$22.49 M(-46.7%)
Sep 2021
-
$9.73 M(-121.2%)
$42.19 M(-173.2%)
Jun 2021
-
-$46.01 M(-178.0%)
-$57.61 M(-252.2%)
Mar 2021
-
$59.01 M(+203.3%)
$37.85 M(-302.2%)
Dec 2020
-$18.72 M(-123.5%)
$19.45 M(-121.6%)
-$18.72 M(-227.5%)
Sep 2020
-
-$90.07 M(-282.1%)
$14.68 M(-89.8%)
Jun 2020
-
$49.45 M(+1925.9%)
$143.26 M(+42.2%)
Mar 2020
-
$2.44 M(-95.4%)
$100.75 M(+26.4%)
Dec 2019
$79.70 M
$52.86 M(+37.3%)
$79.70 M(+86.7%)
DateAnnualQuarterlyTTM
Sep 2019
-
$38.51 M(+454.9%)
$42.69 M(+4185.7%)
Jun 2019
-
$6.94 M(-137.3%)
$996.00 K(-90.7%)
Mar 2019
-
-$18.61 M(-217.4%)
$10.70 M(+80.6%)
Dec 2018
$5.93 M(-104.9%)
$15.84 M(-598.2%)
$5.93 M(-103.7%)
Sep 2018
-
-$3.18 M(-119.1%)
-$159.67 M(+13.6%)
Jun 2018
-
$16.65 M(-171.2%)
-$140.55 M(-2.3%)
Mar 2018
-
-$23.38 M(-84.4%)
-$143.86 M(+18.6%)
Dec 2017
-$121.27 M(-364.4%)
-$149.76 M(-1039.3%)
-$121.27 M(-270.9%)
Sep 2017
-
$15.94 M(+19.5%)
$70.94 M(+7.0%)
Jun 2017
-
$13.34 M(-1792.5%)
$66.31 M(+110.6%)
Mar 2017
-
-$788.00 K(-101.9%)
$31.49 M(-31.3%)
Dec 2016
$45.86 M(-135.1%)
$42.45 M(+275.3%)
$45.86 M(-196.7%)
Sep 2016
-
$11.31 M(-152.7%)
-$47.44 M(-17.4%)
Jun 2016
-
-$21.48 M(-258.2%)
-$57.45 M(-11.5%)
Mar 2016
-
$13.58 M(-126.7%)
-$64.94 M(-50.3%)
Dec 2015
-$130.56 M(+7751.0%)
-$50.85 M(-4020.4%)
-$130.56 M(+63.8%)
Sep 2015
-
$1.30 M(-104.5%)
-$79.72 M(-1.6%)
Jun 2015
-
-$28.97 M(-44.3%)
-$81.01 M(+55.7%)
Mar 2015
-
-$52.04 M
-$52.04 M
Dec 2014
-$1.66 M(+127.2%)
-
-
Dec 2013
-$732.00 K
-
-

FAQ

  • What is CytomX Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for CytomX Therapeutics?
  • What is CytomX Therapeutics annual CFI year-on-year change?
  • What is CytomX Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for CytomX Therapeutics?
  • What is CytomX Therapeutics quarterly CFI year-on-year change?
  • What is CytomX Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for CytomX Therapeutics?
  • What is CytomX Therapeutics TTM CFI year-on-year change?

What is CytomX Therapeutics annual cash flow from investing activities?

The current annual CFI of CTMX is -$150.67 M

What is the all time high annual CFI for CytomX Therapeutics?

CytomX Therapeutics all-time high annual cash flow from investing activities is $98.26 M

What is CytomX Therapeutics annual CFI year-on-year change?

Over the past year, CTMX annual cash flow from investing activities has changed by -$248.93 M (-253.34%)

What is CytomX Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of CTMX is $18.17 M

What is the all time high quarterly CFI for CytomX Therapeutics?

CytomX Therapeutics all-time high quarterly cash flow from investing activities is $99.82 M

What is CytomX Therapeutics quarterly CFI year-on-year change?

Over the past year, CTMX quarterly cash flow from investing activities has changed by +$61.11 M (+142.31%)

What is CytomX Therapeutics TTM cash flow from investing activities?

The current TTM CFI of CTMX is $97.43 M

What is the all time high TTM CFI for CytomX Therapeutics?

CytomX Therapeutics all-time high TTM cash flow from investing activities is $143.26 M

What is CytomX Therapeutics TTM CFI year-on-year change?

Over the past year, CTMX TTM cash flow from investing activities has changed by +$161.15 M (+252.90%)